Phase Bioscience Announces Collaboration with Centocor Research and Development
News Jan 07, 2008
PhaseBio’s deltaPhase technology offers new solutions for the production and purification of protein-based therapeutics, including polypeptides, proteins or antibodies and provides substantial advantages over current biological production methods.
According to PhaseBio, the advantages seen with its process include: increased yields, high throughput and elimination of chromatography steps for final product purification. “We are extremely pleased that Centocor has decided to extend their successful collaboration with PhaseBio,” stated Clay B. Thorp, Chairman of the Board, Phase Bioscience, Inc.
Under the terms of the agreement, Centocor will have rights to utilize the deltaPhase technology in their research.
Algorithm Unearths Over 1000 Antibiotic Proteins in a Few HoursNews
The algorithm identified 10 times more peptide variations than all previous discoveries combined, aiding the hunt for new antibiotics.READ MORE
Protein That Helps Keep Breast Cancer Dormant IdentifiedNews
A protein kinase that stops breast cancer cells growing and spreading has been outlined in new research.READ MORE
Barrier to Liquid Biopsies Overcome with Blood Stabilization TechniqueNews
A new technique that prolongs the lifespan of blood samples could be a breakthrough for liquid biopsy assays.READ MORE